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The major histocompatibility complex (MHC) ~  was originally defined by means 
of alloreactive immune responses, (1-3), but more recent studies have revealed 
a  physiological role  for  the  MHC  in  the presentation  of foreign (non-MHC) 
antigens to immune T  cells (4, 5). However, any model of the MHC's physiolog- 
ical role in controlling T cell differentiation and function must be able to explain 
why the mature animal possesses such a high frequency of lymphocytes reactive 
to the MHC alloantigens of its own species; this appears to be at least an order 
of magnitude greater than  that  of self-MHC-restricted clones specific for any 
one individual antigen (6-8).  One possible explanation for these findings is to 
postulate that MHC alloantigens, either alone (9) or in some form of association 
with other cell surface components (10,  1 I), display structures that mimic the 
immunogenic determinants that are presented to the T  cell system by certain 
combinations of foreign antigen and self-MHC molecule. Viewed in this way, an 
alloreactive response represents the sum of responses of a  variety of antigen- 
specific immune T  cells all fortuitously induced through cross-reactive epitopes 
present on the aliogeneic cell. A  substantial amount of experimental evidence 
has been presented recently to support the existence of such cross-reactivity (12- 
17)  but,  to date,  all  of this stems from work with  inbred strains of mice; the 
generality of this phenomenon remains an important and unresolved question. 
MHC restriction of cytotoxic T  cell function in man has been demonstrated 
in the response to haptens (18), to minor histocompatibility antigens (19), and to 
viruses (20,  21).  Cytotoxic T  cells specific for Epstein-Barr (EB)  virus can be 
generated in vitro by appropriately challenging the blood mononuclear cells of 
previously  infected (seropositive)  individuals  with  autoiogous  EB  virus-trans- 
formed B cells and the effector cells thus obtained show clear evidence of class I 
MHC  (HLA-A,  B,  C)  antigen restriction  (22).  A  much closer analysis of the 
restriction operative in this system has been made possible through the in vitro 
expansion of these effector cell populations as interleukin 2 (IL-2)-dependent T 
cell lines (23). The testing of such effector cells on large panels of allogeneic EB 
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virus-transformed B cell lines has now begun to reveal instances in which certain 
EB  virus-specific cytotoxic T  cell preparations,  which  display  classically  HLA- 
restricted  recognition  of  the  great  majority  of  targets  tested,  also  show  an 
anomalous  lysis  of particular  HLA-mismatched  target  cell  lines.  The  present 
work shows that this anomalous lysis is directed against epitopes on class I  HLA 
alio-antigens expressed not only on EB virus-transformed but also on mitogen- 
stimulated  target  cells,  and  is  mediated  by the  same  effector cells as  mediate 
virus-specific self-HLA-restricted cytolysis. This,  to our knowledge,  is  the  first 
demonstration that such cross-reactivity exists within the T  cell repertoire of an 
outbred species. 
Materials and Methods 
Blood Donors and HLA Typing.  Blood samples were obtained from healthy adult donors 
whose immune status with respect to EB virus was assessed  by measuring antibodies to 
the EB virus capsid antigen (24), and who were typed for HLA-A, -B, and -C, and HLA- 
DR antigens using peripheral blood mononuclear (PBM) cells and EB virus-transformed 
lymphoblastoid cell lines as described previously (25). 
Cell Lines  and Culture  Medium.  Cell  lines were prepared and passaged as described 
previously (25).  RPMI  1640 culture medium supplemented with 2 mM glutamine,  100 
U/ml penicillin,  100 #g/ml streptomycin, and  10%  fetal calf serum (FCS) was used for 
maintenance of all cell lines and experimental cultures, unless otherwise stated. 
Preparation of EB Virus-specific Effector Cells.  This has been described in detail elsewhere 
(22-25). Briefly 2 X  10  6 PBM cells were cultured with 5 ×  104 X-irradiated autologous 
EB virus-transformed lymphoblasts for  10  d;  at  this time the stimulated  T  cells  were 
harvested by E-rosetting with sheep erythrocytes treated with 2-aminoethylisothiouronium 
bromide hydrobromide and cultured for 4-6 d with autologous X-irradiated stimulator 
cells at a  responder/stimulator ratio of 5:2.  The resulting effector population was  ex- 
panded using I L-2-containing culture supernatants and repeated addition of X-irradiated 
stimulator cells. 
Q~totoxicitv Assays.  The conduct of cytotoxicity  assays, including cold t~rget competition 
experiments, and assays testing the effect of monoclonal antibodies upon cytotoxicity, was 
exactly as described previously (24, 25). Mitogen-stimulated lymphoblasts were prepared 
from cultures of PBM cells either 3 d after exposure to phytohaemagglutinin (PHA) or 5 
d after exposure to pokeweed mitogen (PWM).  On some occasions mitogen-stimulated 
lymphoblasts were cultured in medium containing 15% human AB serum in place of 10% 
FCS. 
Monoclonal Antibodies.  The following monoclonal antibodies were used in cytotoxicity 
blocking studies:- W6/32 and BB7.7 (26), both specific for a framework determinant on 
all  HLA-A, -B, and -C antigens, and TDR 31.1 (27) specific for an HLA-DR common 
framework determinant (all kindly provided by Dr. W. F. Bodmer and Dr. M.J. Crumpton, 
Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London) and MA2.1 
(28),  specific for a  polymorphic determinant on  HLA-A2 and  HLA-B17 (Bw57/w58) 
antigens (kindly provided by Professor A. McMichael, Nuffield Department of Medicine, 
John Radcliffe Hospital, Oxford). 
Analysis  of Results  of Cytotoxicity Assays.  In  order  to allow  comparison  of results  of 
repeated  testing  of the  same  effector/target cell  combination,  the  specific  lysis was 
expressed on each occasion as a percentage of the autoiogous target cell lysis observed in 
the same experiment at the same effector/target ratio. The mean and standard deviation 
of the relative percentage lysis was then calculated for each effector/target combination 
tested across a range of different effector/target ratios (2.5:1  to 20:1). 
Limiting Dilution Culture and Assay Procedure.  Appropriate numbers of T cells from an 
IL-2-dependent cytotoxic T  cell line from donor StG were cultured in U-shaped 0.2-ml 
volume wells  in the presence of 2  ×  I0  "~ X-irradiated stimulator cells,  either from the 
autologous cell line StG or from the HLA-Bw62-bearing cell line JU, and 25%  IL-2- 1806  EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
containing culture supernatant.  IL-2 and culture medium were replaced twice weekly. 
After  10 d,  wells  in  which a  proliferating colony was visible  were subcultured to  2-6 
further U-wells, with 2 x  103 stimulator cells per well. Subculturing and feeding with IL- 
2 and stimulator cells was continued until each colony was of Sufficient size to allow assay 
for cytotoxicity. 
In order to obtain further information on the cytotoxicity  of  a large number of colonies, 
an in situ cytotoxicity assay  was used (29), instead of waiting for sufficient numbers of 
cells to be available for conventional cytotoxicity testing. This was necessary as colonies 
were often slow-growing. Growing colonies were harvested and split into equal aliquots, 
some of which were retained for further culture, while the others were transferred to 
fresh U-shaped well microtest plates for cytotoxicity  assay. After feeding with fresh culture 
medium (without IL-2) the plates were centrifuged briefly, and the supernatant removed 
and replaced with  further fresh  medium.  Cells  were then cultured overnight.  Before 
assay,  replicate colony wells  were checked visually  to ensure that approximately equal 
numbers of effectors cells were present in each assay well.  150 #1 of medium was removed 
from each well by careful suction; 50 #1 of fresh medium and  104 chromiumS~-labeled 
target cells in  100 t~l culture medium were then added. By assaying colonies at least 3 d 
after feeding with IL-2 and replacing the medium three times, negligible amounts of PHA 
were present in the final assay well and there was never any evidence of lectin-mediated 
cytotoxicity. The assay was completed in the normal way. 
Assessment of Results from In Situ Cytotoxicity Assay.  Although low levels of percentage 
specific lysis were recorded by this technique, lysed and nonlysed targets could be clearly 
distinguished; thus wells were scored positive for lysis if >4.5% specific lysis was observed 
(representing an  isotope release  93  standard  deviations higher  than  the  spontaneous 
release obtained from 4-6 control wells containing target cells alone). <2% specific isotope 
release was observed in wells scored as negative for lysis. Most colonies were assayed on 
2-4 separate occasions with excellent agreement between the results on each occasion. 
Experimental  Procedure.  EB virus-specific cytotoxic T  cell lines were established from 
virus-immune donors and tested on a  large panel of HLA-typed EB virus-transformed 
lymphoblastoid target cells.  From this analysis,  the identity of the dominant self HLA- 
determinants restricting each effector cell population could be determined, and instances 
of"anomalous" lysis of H LA mismatched target cells noted. The nature of the ~anomalous" 
cytotoxicity was further investigated, (a) by extending the target cell panel to include EB 
virus-genome-negative mitogen-stimulated  lymphoblasts  from  a  range  of HLA-typed 
donors, (b) by monoclonai antibody blocking studies using antibodies specific for mono- 
morphic (framework) or polymorphic determinants on class I HLA antigens, and (c) by 
cold target inhibition  experiments to  compare the  "anomalous" and  EB virus-specific 
components of cytotoxicity. 
Finally, one particular effector T  cell line displaying both "anomalous" and EB virus- 
specific cytotoxicities was seeded at limiting dilutions and the resulting colonies assayed 
for both cytotoxic functions. 
Results 
Demonstration of Alloreactivity in an EB Virus-specific Self-HLA-restricted Cytotoxic  T 
Cell Population.  Fig.  1 presents an analysis of the cytotoxicity displayed by an 
effector T  cell  line obtained  from the  seropositive (i.e.,  virus-immune)  donor 
JuG (HLA-A 1, A2, B8, B14) by appropriate in vitro stimulation with autologous 
EB  virus-transformed  B  cells.  It  is  clear  from  a  that  iysis  was  preferentially 
directed towards the autologous stimulating cells and towards those allogeneic 
EB virus-transformed target cells sharing HLA-B8 in common with donor JuG. 
A  lower  level  of  killing  was  observed  with  HLA-B14-matched  target  cells, 
whereas there was no significant lysis of target cells sharing only HLA-A 1 or - 
A2  with  the  effector cells.  The  HLA-restricted  nature  of the  cytotoxicity is 
further  supported  by  the  results  obtained  with  the  10  HLA-mismatched  EB GASTON  ET  AL.  1807 
virus-transformed target cell lines shown on the left of b, none of which were 
lysed. Moreover, the EB virus specificity of these effector cells is apparent from 
their lack of reactivity when tested against autologous or HLA-B8/B14-bearing 
mitogen-stimulated lymphoblasts (c) or against the NK-sensitive target cell lines 
HSB2 and K562 (<10% relative lysis, data not shown). 
However, as shown by the remaining results in b,  five target cell lines com- 
pletely  mismatched  for  class  I  HLA  antigens  (or  sharing  only  HLA-A2,  an 
antigen  that does not  mediate virus-specific cytolysis by JuG  effector T  cells) 
were  unexpectedly lysed  at  significant  levels.  This  result  did  not  reflect  any 
unique sensitivity of these particular targets to cytolysis per se since in numerous 
other assays these same lines were not killed by EB virus-specific effector T  cell 
preparations from other HLA-mismatched donors (data not shown). The allo- 
reactive nature of this "anomalous" lysis was first suggested by the parallel results 
shown  in  c.  Thus,  where  testing  was  possible,  PHA-stimulated  lymphoblasts 
prepared from these same individuals were also found to be sensitive to "anom- 
alous"  cytolysis by  the JuG  effector  T  cell  line.  This  result  was  obtained  on 
several occasions of testing,  irrespective of whether the  mitogenic stimulation 
was carried out using fetal calf serum or human AB serum (Fig.  1 legend). 
Subsequent studies showed that high titer preparations of two different mono- 
clonal antibodies (W6/32 and BB7.7), directed against framework determinants 
common to all class I  HLA molecules, blocked this "anomalous" lysis of HLA- 
mismatched target lines very efficiently (74% and 82% inhibition for W6/32 and 
BB.7.7, respectively, cf. 81% and 52% inhibition of HLA-restricted virus-specific 
lysis in the same experiments). However, identification of the polymorphic class 
I HLA determinant against which "anomalous" lysis was directed in this particular 
case was difficult since no serologically defined HLA-antigen was common to all 
five sensitive targets (see Discussion). 
Demonstration  of Alloreactivity  Against  an  Identifiable  Serotogicatty Defined HLA 
Alloantigen..  By contrast, Fig. 2 provides data obtained using another EB virus- 
specific cytotoxic T  cell line with an alloreactive component, where it was indeed 
possible to identify the particular  antigen against  which the alloreactivity was 
directed.  In this example, the effector T  cell line from seropositive donor JU 
(HLA-A2,  A2,  Bw62,  Bw62) displayed an  EB virus-specific cytotoxic function 
predominantly  restricted  through  HLA-Bw62,  with  little  A2-restricted  lysis. 
HLA-mismatched target cell lines were not lysed, with the striking exception of 
all four target cell lines tested that were positive for HLA-Bw57; these showed 
unusually high levels of lysis and again this "anomalous" reactivity ofJU effector 
T  cells  extended  to  include  HLA-Bw57-bearing  mitogen-stimulated lympho- 
blasts (Fig. 2) in tests where all other EB virus-genome-negative target cells were 
not killed (data not shown). 
• The availability of the monoclonal antibody MA2.1,  which is specific for an 
epitope shared only by HLA-A2 and -Bw57/Bw 58 antigens, allowed testing of 
the hypothesis that HLA-Bw57 was the target antigen for this "anomalous" lysis. 
As shown in Fig.  3, high titers of MA2.1  blocked "anomalous" lysis of the two 
Bw57-bearing target lines RT and TH just as efficiently as did the monoclonal 
antibody  BB7.7  which  binds  to  a  common determinant  on  all  class  I  HLA 
molecules; this result suggested that Bw57-directed alloreactivity was responsible 1808  EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
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for all of the observed iysis of RT and TH cell lines. In this same experiment, 
the EB virus-specific HLA-Bw62-restricted cytotoxicity of JU effector T  cells 
directed against the autologous cell line was selectively blocked by the binding 
of BB7.7, but not of MA2.1, to these target cells. 
Demonstration  of Alloreactivity Against a  "Public" Determinant  Shared  by Certain 
HLA  Antigen  Types/Subtypes.  Table  I  summarizes  the  results  obtained  with 
repeated testing of an  effector T  cell  line derived from another seropositive 
donor, StG (HLA-A1, A2,  B8,  B8), on a  large panel of EB virus-transformed 
target cells. In this case, EB virus-specific cytolysis was restricted largely through 
HLA-B8 and to a lesser extent through HLA-A2, whilst there was no detectable 
HLA-Al-restricted component. Testing of HLA-mismatched target cell lines 
revealed a strikingly reproducible pattern of "anomalous" cytotoxicity affecting 
all H LA-Bw35-bearing, all HLA-Bw62-bearing and subset of HLA-B12-bear- 
ing (HLA-Bw44, w45) targets. 
The alloreactive nature of these "anomalous" cytotoxicities of the StG effector 
T  cell line was made clear by the results in  Fig.  4.  Thus,  not only EB virus- 
transformed cells but also mitogen-stimulated lymphoblasts from relevant donors 
bearing either HLA-Bw62  or -Bw35 or -Bw44  were sensitive to  "anomalous" 
lysis, whereas lysis of autologous or of HLA-matched targets was specific for EB 
virus-transformed cells only. Again the "anomalous" lysis of HLA-mismatched 
targets was strongly inhibited (<80%) by the class I HLA antigen-specific mono- 
clonal antibody W6/32; in a parallel experiment the class II HLA antigen specific 
monoclonal antibody TDR31.1  inhibited lysis by <5% (data not shown). 
Fig. 5 shows representative results of cold target inhibition experiments that 
were conducted in  order  to  determine the  relationship,  if any,  between  the 
alioreactive responses directed against HLA-Bw62,  -Bw35,  and -Bw44 respec- 
tively. Unlabeled target cells expressing any one of these antigens were capable 
of significantly inhibiting the "anomalous" lysis of the Bw35-bearing cell line M7 
(Fig. 5  a) or of HLA-Bw44- or HLA-Bw62-bearing cell lines (data not shown). 
Mitogen-stimulated lymphoblasts were just as effective cold target inhibitors as 
were the corresponding EB virus-transformed cells (see DW-blast results, Fig. 5 
a). 
An analogous series of cold target inhibition experiments was performed to 
FIGURE  1.  Cytotoxicity of an effector T  cell line from donor JuG (A 1, A2; B8, B 14) tested 
on: (a) EB virus-transformed target cells whose degree of HLA-A and -B antigen matching 
with the effector cells is as shown; (b) EB virus-transformed target cells not sharing any HLA- 
A and -B antigens with the effector cells and (c) mitogen-stimulated EB virus-genome-negative 
lymphoblasts, both HLA-matched and -mismatched with the effector cells. Lysis of autologous 
target cells is shown by the hatched columns. The relative percentage lysis shown for each 
target represents the specific lysis of that target cell expressed as a percentage of the specific 
lysis of the EB virus-transformed autologous (JUG) target cell obtained in the same assay at 
the same effector/target ratio; the mean relative percentage lysis from between two and eight 
assays is shown for each target cell. (*Target cells AD, AMc, RT, and M7 were serologically 
typed as bearing HLA-A2 antigens but are as shown as HLA-mismatched targets since they 
express "variant" HLA-A2 antigens as defined by T  cell-restricting determinants [reference 
2.5].) In addition to the results shown in c, when PHA-stimulated lymphoblasts from donors 
GB and FB were cultured and assayed in medium containing either FCS or human AB serum, 
the results expressed in terms of relative percentage lysis (at effector/target ratio 5:1) were as 
follows: In FCS containing-medium, GB blasts 99%, FB blasts 89%; in AB serum containing- 
medium, GB blasts 85%, FB blasts t 10%. 1
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FmURE 3.  Effect of monoclonal antibodies on the level of EB virus-specific lysis of autologous 
target cells, and on the level of "anomalous" lysis of HLA-Bw57-bearing target cells mediated 
by effector T  cells from donor JU.  Results are expressed as percentage specific lysis in the 
absence of antibody (hatched columns) and in the presence of saturating concentrations of 
monoclonal antibody BB7,7 (stippled  columns) or monoclonal antibody MA2.1 (open columns). 
TABLE  I 
Summary of StG Effector T Cell Reactivities* 
1811 
Proportion 
Targets  Mean relative  of targets 
Type of reactivity  Targets grouped by HLA type  per  lysis (m.r.l.)  with >25% 
group  m.r.l.* 
EBV-specific 
"Allospecific" 
Auto (AI, 2, B8)  1  100  1/I 
A1 match  3  11 4- 7  0/3 
A2 match  4  44 4- 12  4/4 
A1B8/B8 match  6  71 4- 42  6/6 
A2B8 match  4  72 4- 16  4]4 
No match  15  9 4- 7  0/15 
Bw35 cross-reaction  9  70 4- 37  9/9 
Bw62 cross-reaction  5  63 4- 20  5/5 
B 12 cross-reaction 
(a)  Bw44/45 subgroup  9  56 4- 15  9/9 
(h)  Bw44 subgroup  4  9 4- 2  0/4 
* Effector T  cells from donor StG were tested on a large number of target cells; for each target cell 
tested the relative percentage lysis was calculated as described in Fig. I legend from the results of 
several assays. Target cells are arranged in groups according to expression of HLA antigens shared 
with donor StG or expression of HLA antigens mediating alloreactivity; the mean relative percent- 
age lysis (m.r.l.) values for all the target cells in each group is shown  along with the standard 
deviation. 
* The proportion of target cells within each group showing a relative percentage lysis of >25% when 
tested in several assays. 
determine  whether  the  alloreactivity  of  the  polyclonal  StG effector  cell  line 
reflected genuine  cross-reactive lysis by virus-specific self-HLA-restricted  effec- 
tor  T  cells or  was  being  mediated  by a  separate  population  of effectors.  The 
results showed that unlabeled targets bearing any one of the relevant alloantigens, 
for instance either EB virus-transformed cells or mitogen-stimulated lymphoblasts 
from the HLA-Bw62-positive donor JU "(Fig. 5  b), were capable of significantly 
inhibiting lysis of autologous  EB  virus-transformed  targets by the  StG effector 1812  EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOXIC  T  CELLS 
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FIGURE  4.  Cytotoxicity of an effector T  cell line from donor StG (A1, A2; B8, B8) tested on 
either EB virus-transformed cells (hatched columns) or mitogen-stimulated lymphoblasts (filled 
columns) whose degree of H LA-A and -B antigen matching with the effector cells is as shown. 
Target cells bearing the "cross-reactive" antigens, HLA-Bw62 or -Bw35 or -Bw44, are also 
indicated. For each target ceil, the results are expressed as relative percentage lysis as described 
in Fig.  1 legend. 
cell line. The degree of inhibition, while less than that shown by unlabeled cells 
of the autologous cell  line  itself,  was nevertheless equal  to  that  shown  by an 
HLA-matched cell line JuG (from the mother of donor StG) and clearly much 
greater than the background effects caused by irrelevant cold targets (Fig. 5  b). 
Conversely, alloreactive lysis by the StG effector T  cell line could in each case 
be inhibited by unlabeled cells of the autologous virus-transformed cell line StG 
(Fig. 5  a) and of the HLA-matched cell line JuG (data not shown). 
Analysis  of Virus-specific and  Alloreactive  Cytotoxicities by Limiting Dilution  of the 
Effector T Cell Line.  Limiting dilution culture of the polyclonal StG effector T 
cell line provided an independent approach with which to assess the relationship 
between virus-specific and alloreactive cytotoxicities. In these experiments, the 
parent cell line was found to have a low plating efficiency and growing colonies 
were never obtained at seedings below 5 cells/well. The cell populations obtained 
could  therefore  not  be  designated  as  clones.  Of the  colonies  derived  from 
seedings of 5-40 cells/well, 24 of 72 colonies tested proved to be cytotoxic. 
Fig. 6 presents the individual results from four such cytotoxic colonies chosen 
to illustrate the patterns of lysis most commonly obtained. In the upper panel, 
the two  colonies (SBI 1,  20  ceils/well; JD3,  5  ceils/well) displayed autoiogous 
target lysis as well as lysis of all  three cross-reacting targets (DW, JU, and M7 
bearing  HLA-Bw44,  Bw62,  and  Bw35,  respectively) while another HLA-mis- 
matched target line, RC and the NK-sensitive target line HSB2 were not killed. 
In all,  18 colonies showed this pattern.  In contrast the lower panel shows two 
colonies (SB9, 20 cells/well; SA 11, 40 cells/well) whose cytotoxicity was prefer- 
entially directed towards the autologous cell line with no evidence of any cross- 
reactivity against the relevant targets DW, JU, and M7; one further colony (40 
cells/well) showed this pattern. A further three colonies (seeded at 20-40 cells/ 
well) arising in the same experiment appeared to lyse the autologous target cells 60 
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FIGURE 5.  (a) "Anomalous" ]ysis of the HLA-Bw35-bearing cell line M7-EB and (b) EB virus- 
specific lysis of the autologous cell line StG -EB by effector T  cells from donor StG (effector/ 
target ratio  5:1)  in the presence of varying numbers  of cold target competitor cells whose 
expression of HLA-A and -B antigens matched with the effector cells or of "cross-reactive" 
HLA antigens (Bw35, Bw44, Bw62) is shown. The notations -EB and -blast refer to EB virus- 
transformed and mitogen-stimulated cold target competitor cells respectively. 
and only one of the cross-reacting targets,  but in each of these three cases the 
pattern of reactivity could not be unequivocally identified because the levels of 
killing observed were borderline. Throughout this work, no colonies were found 
in which cross-reactive lysis occurred in the absence of cytotoxicity against  the 
autologous virus-transformed line. 1814  EPSTEIN-BARR  VIRUS-SPECIFIC  CYTOTOX1C  T  CELLS 
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FIGURE 6.  Cytotoxicity of four colonies derived from a limiting dilution analysis of effector 
T  cells from donor  StG,  tested on the autologous EB virus-transformed cell line (hatched 
columns), on the EB virus genome-negative cell line HSB2 and on the HLA-mismatched EB 
virus-transformed cell line RC, and on target cells expressing the "cross-reactive" HLA-Bw44 
(DW), -Bw62 (JU) or -Bw35 (M7) antigens. The results are expressed as percentage specific 
lysis. Colonies are designated according to initial number of cells seeded per well in limiting 
dilution as follows: A, 40 cells/well; B, 20 cells/well; £,  10 cells/well; D, 5 cells[well. Colonies 
are  designated  S  or J  depending  on  whether  they  were  initially seeded  on  X-irradiated 
stimulator cells from  the autologous (S)  or from the  HLA-Bw62-bearing JU (J)  EB virus- 
transformed cell line. The plating efficiency was slightly higher with seeding on autologous 
stimulator cells but colonies showing autologous cell lysis and cross-reactive lysis were obtained 
by both methods. 
Discussion 
Investigations  in  this  (21,  24,  30) and  in  several  other  (31-34)  laboratories 
have shown that EB virus-specific cytotoxic T  cells can be prepared by in vitro 
reactivation  from memory cells in the blood of virus-immune donors, and that 
such  effector  cells  are  HLA-A  and  -B  antigen-restricted  in  their  function. 
However, a rigorous analysis of the restriction  operative in this system has only 
recently been made possible through the development of IL-2-dependent effec- 
tar T  cell  lines that retain  the EB virus-specific  HLA-restricted  function of the 
original  preparations  from which  they were derived  (23).  The  present  investi- 
gation was initiated once it became clear that certain effector T  cell lines, which GASTON ET AL.  1815 
in  all  other respects exhibited classical  HLA-A and  HLA-B antigen-restricted 
function, nevertheless showed "anomalous" lysis of particular HLA-mismatched 
targets. Detailed results from three effector T  cell lines with such "anomalous" 
reactivity are described in the present paper. These are not isolated examples, 
however, for this same phenomenon has been observed in the functional analysis 
of several other EB virus-specific effector T  cell lines derived from other donors 
and tested in this laboratory. 
The results demonstrate that  "anomalous" lysis of HLA-mismatched targets 
occurred irrespective of the  EB  virus  genome status  of the  target  cell,  and 
appeared to be directed against class I alIo-HLA determinants expressed on the 
target cell surface. Thus, in each case, both EB virus-transformed and mitogen- 
stimulated lymphoblasts from the particular allogeneic donors in question were 
sensitive to "anomalous" lysis (Figs.  1,  2, and 4), in contrast to the reactivity of 
these same effector cells against autologous or HLA-matched targets where lysis 
was confined to the EB virus-transformed cell line only. Moreover "anomalous" 
lysis could be specifically inhibited by monoclonal antibodies binding to frame- 
work determinants on all class I HLA antigens (Fig. 3), the degree of inhibition 
being at  least as strong,  if not stronger, than that observed when these same 
effector cells were simultaneously tested for EB virus-specific lysis of the autolo- 
gous virus-transformed cell line. 
The  target  structure  for  "anomalous" cytotoxicity therefore appears  to  be 
either a  determinant  expressed  by  a  class  I  alIo-HLA  molecule per  se  or an 
"interaction antigen" (10,  11) formed by an alIo-HLA molecule and some other 
(non-EB virus-associated) cell surface component. A precedent for the latter view 
comes from studies in the mouse system (35) in which cloned cytotoxic T  cells 
specific for a minor transplantation antigen restricted by a self H-2K allele were 
found also to recognize a different minor transplantation antigen in the context 
of an allogeneic H-2D allele. The present experiments cannot determine whether 
a second antigen is being recognized in the context of alIo-HLA, although they 
can eliminate fetal calf serum proteins in culture medium as possible contributors 
to such an "interaction antigen" since mitogen-stimulated lymphoblasts prepared 
in medium containing human AB serum were equally sensitive to "anomalous" 
lysis  (Fig.  1  legend and  unpublished  results).  It  was  necessary to  check this 
particular point since there are circumstances in which fetal calf serum-directed 
cytotoxicity can contaminate otherwise EB virus-specific cytotoxic T  cell prepa- 
rations (36, 37). 
Although the alloreactive nature of "anomalous" lysis has been clearly dem- 
onstrated, the identity of the target allo-antigen has not always been determined. 
Thus,  in  the  first  example  shown  by  the JuG  effector T  cell  line,  no  one 
seroiogically defined HLA-A, -B, or -C antigen was shared by all the five targets 
that  were sensitive to  "anomalous" lysis  (Fig.  1).  Yet  in  this  case cold target 
inhibition  studies clearly showed mutual cross-inhibition within this  group  of 
targets (data not shown), suggesting that each was being recognized through its 
expression of a common ailodeterminant. Perhaps the most likely candidate for 
such a determinant would be an epitope shared by the serologically related HLA- 
A3  and -A11  antigens,  since all  five targets expressed one or other of these 
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In contrast, the target antigen responsible for allo-recognition by the EB virus- 
specificJU effector T  cell line was positively identified as HLA-B17 (Bw57). Not 
only was "anomalous" lysis  confined to Bw57-bearing target cells (Fig.  2),  but 
also the killing was strongly inhibited by the monoclonal antibody MA2.1.  In 
contrast, binding of MA2.1  to the HLA-A2-bearing autologous target cell line 
JU did not reduce its EB virus-specific lysis by the same effector population since 
most of this activity was restricted through another determinant (HLA-Bw62) 
on  the  target  cell  surface.  These  particular  results  suggest  that  in  this  case 
effector cells specific for the EB virus-induced lymphocyte-detected membrane 
antigen  (LYDMA)  presented  in  the  context  of  HLA-Bw62  (self-HLA)  were 
recognizing a cross-reacting epitope presented by the HLA-Bw57 molecule. It is 
interesting  to  note  here  that  Bw62  and  Bw57  do  share  some  cross-reactive 
epitopes as revealed by HLA-typing sera (38) so that the interaction of LYDMA 
with Bw62 might present one or more such epitopes in an immunogenic form 
to the T  cell system. 
Analysis of the "anomalous" reactivity of the StG effector T  cell line revealed 
a complex relationship between the target alloantigen recognized by T  cells and 
the serologically defined polymorphism of HLA antigens.  Thus, lysis  involved 
all of the Bw35-bearing, all of the Bw62-bearing and a subset of the B 12-bearing 
targets tested (Table I). This subdivision of B 12, while clearly distinct from the 
serologically defined split into Bw44 and Bw45 sub-types, is strikingly similar to 
that  recently  reported  by  other  workers  using  anti-B12  alloreactive  T  cells 
generated in a  standard  mixed lymphocyte culture (39,  40).  The fact that all 
three alloreactivities, against Bw35, Bw62, and B12, respectively, showed consid- 
erable mutual cross-inhibition in cold target inhibition experiments (Fig. 5 and 
unpublished  results)  strongly  suggested  that  they  share  a  "public"  specificity 
against which the "anomalous" cytotoxicity of StG effector T  cells is directed. In 
this context, it is interesting to note that cross-reactions between Bw35 and Bw62 
and between B 12 and Bw35 have been identified by serological and cell-mediated 
lympholysis techniques (38, 41, 42). To our knowledge this is the first identifi- 
cation of a determinant common to all three antigens. 
A  central  question posed by these findings is whether the alloreactivity ob- 
served is a genuine cross-reactivity displayed by the EB virus-specific effector T 
cells themselves or whether it represents a separate reactivity emerging pari passu 
with  the  expansion  of virus-specific  effector  cells  in  IL-2.  As  a  preliminary 
approach to  this question,  cryopreserved  samples of the  original  effector cell 
preparations from which the IL-2-dependent StG and JuG effector T  cell lines 
were  derived  were  thawed  and  the  cells  tested  on  a  representative  series  of 
targets; "anomalous" lysis of selected HLA-mismatched targets was again appar- 
ent even at this early stage (unpublished experiments). Subsequent cold target 
inhibition experiments supported the view that both virus-specific and alloreac- 
tive cytotoxicities were being mediated by the same effector cells. For example, 
using  StG  effector  T  cells,  alloreactive  lysis  could  be  strongly  inhibited  by 
unlabeled target cells of the autologous EB virus-transformed cell line (Fig. 5  a) 
but not by autologous mitogen-stimulated lymphoblasts (data not shown), while 
EB virus-specific cytolysis was  itself significantly inhibited either by  EB  virus- 
transformed cells or by mitogen-stimulated lymphoblasts bearing  the relevant GASTON  ET  AL.  1817 
alloantigen (Fig. 5  b). Several other examples of alloreactivity, including those 
displayed by the JuG andJU effector T  cell lines, have been analyzed in a similar 
way and these have always shown significant cross-inhibition between the virus- 
specific and alloreactive components of the cytotoxicity, although the strength 
of mutual cross-inhibition did vary between individual examples. 
The relationship between virus-specific and alloreactive cytotoxicities of the 
StG effector cell line was further pursued by limiting dilution culture. Although 
the relatively poor colony-forming ability of this line meant tht formal criteria 
for cloning could not be satisfied, colonies were isolated that maintained cytotox- 
icity  against  the  autologous  line  but  that,  unlike  the  bulk  culture,  had  no 
alloreactivity;  on the other hand,  all colonies that displayed aUoreactivity also 
maintained  virus-specific cytotoxicity (Fig.  6).  This  latter  result  could not be 
accounted for on the basis of a less stringent limiting dilution procedure used in 
these particular cases; in fact, those colonies showing only virus-specific lysis were 
all derived from wells at the higher cell seedings (20-40 cells/well), while those 
colonies derived from wells at the lowest cell seeding (5 cells/well) displayed both 
virus-specific and alloreactive cytotoxicities.  The inference from these experi- 
ments, namely that the StG effector T  cell line is composed of clones showing 
virus-specific lysis only and of clones showing virus-specific and alloreactive lysis, 
is entirely consistent with the earlier results from cold target inhibition experi- 
ments (Fig. 5). 
The  overall  evidence  therefore  strongly  supports  the  view  that  EB  virus- 
specific, self HLA-restricted  cytotoxic T  cells can recognize cross-reactive epi- 
topes presented by class I  HLA alloantigens. To our knowledge this is the first 
demonstration in an outbred species (i.e., man) of a phenomenon that is becoming 
well recognized in studies with inbred mouse strains using either virus-specific 
(13,  16, 43) or minor transplantation antigen-specific (12,  14, 35, 44) cytotoxic 
T  cells. Indeed it should be stressed that such cross-reactivities appear to be quite 
common  in the EB virus system, having been detected in most if not all of the 
polyclonal effector T  cell  populations  that  have  been  closely analyzed  in  the 
course of this work. Such a result is not surprising in that the various target cells 
used  in  such  an  analysis  are  derived  from  many  different  individuals  of an 
outbred species and  thus provide a  much greater  variety of allodeterminants 
than  are  conventionally  tested  in  analogous  murine  systems;  the  chances  of 
recognizing fortuitous cross-reactions are therefore correspondingly increased. 
Finally, the present studies give support to the thesis that alloreactive responses 
are  derived from within the antigen-specific self-MHC-restricted  T  cell reper- 
toire,  a  view that  carries  with  it  the  rider  that certain  antigen-specific T  cell 
clones restricted through one self-MHC determinant could show cross-reactivity 
against a  different self-MHC  molecule. In fact, such clones would be expected 
to be either suppressed or deleted in the self-tolerant animal (45, 46) and indeed 
this may explain why in certain mouse strains, for instance, particular combina- 
tions of class  I  MHC  molecule and viral  antigen  do not appear  to induce an 
effective T  cell  response  (47,  48).  Preferential  restriction  of effector T  cells 
through some but  not all  of the available  class  I  MHC  antigens is also a  well 
recognized feature of the cytotoxic T  cell response to EB virus in man (24) and 
the present  demonstration  of the alloreactive  potential  of these  virus-specific 1818  EPSTEIN-BARR VIRUS-SPECIFIC CYTOTOXIC  T  CELLS 
cytotoxic T  cells  is  particularly interesting in  the  light of the  model  outlined 
above. 
Summary 
Epstein-Barr (EB) virus-specific cytotoxic T  cells, prepared from virus-immune 
donors by reactivation in vitro and maintained thereafter as IL-2-dependent T 
cell  lines,  have  been  tested against  large  panels of EB  virus-transformed lym- 
phoblastoid  cell  lines  of known  HLA  type.  Whilst the  pattern  of lysis of the 
majority  of  targets  was  always  consistent  with  HLA-A  and  HLA-B  antigen 
restriction of effector function, in several cases it was noticed that certain HLA- 
mismatched targets were also reproducibly lysed. When this "anomalous" lysis 
was investigated in detail, it was found to be directed against allodeterminants 
on class I HLA antigens; thus, mitogen-stimulated as well as EB virus-transformed 
lymphoblasts from the relevant target cell donors were sensitive to the killing, 
and in each case the lysis could be specifically blocked by monoclonal antibodies 
to class I HLA antigens. In one example the target for this alloreactive lysis could 
be  identified as  a  single  serologically  defined  antigen,  HLA-Bw57,  while  in 
another example lysis was directed against a  "public" epitope common to HLA- 
Bw35, -Bw62, and a subset of-B12 antigens. Both cold target inhibition experi- 
ments and limiting dilution analysis strongly suggested that this alloreactive lysis 
was being mediated by the same effector T  cells that recognize EB viral antigens 
in the context ofself-HLA. This is the first demonstration in man that alloreactive 
responses can be derived from within the antigen-specific, self MHC-restricted 
T  cell repertoire. 
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